Home - Products - Others - Other Targets - Tectorigenin 7-?O-?Xylosyl Glucoside

Tectorigenin 7-?O-?Xylosyl Glucoside

CAS No. 231288-19-0

Tectorigenin 7-?O-?Xylosyl Glucoside( Tectorigenin 7-O-xylosylglucoside )

Catalog No. M29234 CAS No. 231288-19-0

Tectorigenin 7-O-xylosylglucoside is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 372 In Stock
5MG 244 In Stock
10MG 361 In Stock
25MG 606 In Stock
50MG 828 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tectorigenin 7-?O-?Xylosyl Glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Tectorigenin 7-O-xylosylglucoside is a natural product.
  • Description
    Tectorigenin 7-O-xylosylglucoside is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tectorigenin 7-O-xylosylglucoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    231288-19-0
  • Formula Weight
    594.522
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1c(O[C@@H]2O[C@H](CO[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Luvangetin

    Luvangetin may have anti-inflammatory activity, it can inhibit NO and PGE2 production in LPS-stimulated BV2 cells.

  • guvacine hydrobromid...

    Guvacine hydrobromide, an alkaloid found in the nut of Areca catechu, is a potent GABA uptakp inhibitor. Guvacine hydrobromide inhibits rat GAT-1, rat GAT-2 and rat GAT-3 with IC50 values of 39 μM, 58 μM and 378 μM, respectively.

  • RBC10

    RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines.